Diabetic Insights
2046 articles
- How Poor Glycemic Control Accelerates Dental Decay Progression
- Understanding the Symptoms of Tooth Decay in Diabetics
- Signs of Tooth Decay to Watch for in Diabetic Individuals
- Understanding School Policies on Diabetes Care and Emergency Response
- How to Address Insurance and Funding Challenges in Supporting Diabetic Students
- How to Advocate for Extended Testing Time and Breaks for Diabetic Students
- The Role of Educational Assistants in Supporting Diabetic Students Under a 504 Plan
- How to Address Emotional and Psychological Support for Diabetic Students in Schools
- The Impact of a 504 Plan on Academic Performance and Well-being of Diabetic Students
- How Teachers Can Support Diabetic Students with a 504 Plan During Exams
- The Role of Peer Support in Achieving Running Milestones for Diabetics
- How to Leverage Community Resources and Events to Motivate Diabetic Runners
- The Importance of Community Support for Diabetics Pursuing Running Goals
- Serum Levels of Fibroblast Growth Factor 19 as a Biomarker for Metabolic Regulation in Diabetes
- The Impact of Circulating Monocyte Chemoattractant Protein-1 in Diabetic Vascular Inflammation
- Biomarkers of Oxidative DNA Damage in Diabetes and Its Complications
- The Role of Circulating Vascular Endothelial Growth Factor in Diabetic Retinopathy Risk Assessment
- Serum Matrix Metalloproteinases as Indicators of Vascular Remodeling in Diabetes
- The Utility of Circulating Tgf-β1 as a Biomarker for Diabetic Nephropathy Progression
- The Significance of Serum Lipoprotein Lipase Activity as a Diabetes Biomarker
- Emerging Biomarkers for Predicting Response to Diabetes Pharmacotherapy
- The Role of Plasma Sphingosine-1-phosphate in Diabetes-related Vascular Dysfunction
- Biomarkers of Serum Fibrosis Markers in Diabetic Kidney Disease
- The Use of Circulating Endothelial Microparticles as Biomarkers for Vascular Damage in Diabetes
- The Potential of Serum Angiopoietin-2 as a Marker for Diabetic Microvascular Complications
- Biomarkers of Pancreatic Beta-cell Stress in Newly Diagnosed Diabetes Patients
- Emerging Biomarkers for Non-invasive Detection of Diabetic Skin Microangiopathy
- The Role of Circulating Lipoprotein(a) as a Cardiovascular Risk Biomarker in Diabetes Patients
- Serum Irisin Levels as a Biomarker for Physical Activity and Metabolic Health in Diabetes
- The Utility of Serum Dipeptidyl Peptidase-4 as a Biomarker in Diabetes Therapy Response